cas 1672663-10-3|| where to buy 4-Fluoro-7-(methylthio)-2,3-dihydro-1H-inden-1-one

Produktname:4-Fluoro-7-(methylthio)-2,3-dihydro-1H-inden-1-one

IUPAC Name:4-fluoro-7-(methylsulfanyl)-2,3-dihydro-1H-inden-1-one

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM290140-1g	in stock	Ⱥțũư

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1672663-10-3 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1672663-10-3; Molekulare Formel:C10H9FOS; Schmelzpunkt:-; SMILES-Code:O=C1CCC2=C1C(SC)=CC=C2F; Dichte:

: Katalognummer:CM290140; Molekulargewicht:196.24; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Indenes; Indenes are useful building blocks found in a variety of biologically relevant products.

: Belzutifan; On September 19, MSD announced that the U.S. FDA has accepted and granted priority review for a supplemental new drug application (sNDA) seeking approval for Welireg (Belzutifan), Merck's oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult patients with advanced renal cell carcinoma (RCC). Welireg was the first HIF-2α inhibitor therapy approved in the U.S. and is currently approved for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated RCC, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.